On SAVA's fourth-quarter 2024 earnings call, investors can expect updates regarding the company's pipeline developmental plans amid recent setbacks.
Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end. The Austin, Texas-based biotech revealed that simufilam failed its ...
Take two at bedtime.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
President Trump called Volodymyr Zelensky a “dictator without elections” after the Ukrainian president said Mr. Trump was in a “web of disinformation.” By Andrew E. KramerConstant ...
Ignored for most of its existence, the huge ice-bound island has been thrust into a geopolitical maelstrom. It’s trying to make the most of it. By Jeffrey Gettleman and Ivor Prickett Riyadh is ...
US President Donald Trump questioned the $21 million US allocation for voter turnout in India, during the FII PRIORITY Summit. He highlighted India's strong economy and high tariffs on US goods.
Feb. 18, 2025 — It may be the smallest, shortest chorus dance ever recorded. An international team of researchers observed how electrons, excited by ultrafast light ... Coffee Grounds and Reishi ...
Feb. 18, 2025 — The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study ...
Leading progressive Canadian journalists respond to Trump’s tariff threats, offering insight into how the trade spat is reshaping Canadian politics and US-Canada relations. In spite of the ...
Today, we need fearless journalism that tackles our most urgent crises and inspires action. Movements fighting exploitation, the climate crisis, and systemic injustice depend on us to amplify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results